These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 15794711)
21. Cholesterol-lowering drug therapy in a patient with receptor-negative homozygous familial hypercholesterolaemia. Feher MD; Webb JC; Patel DD; Lant AF; Mayne PD; Knight BL; Soutar AK Atherosclerosis; 1993 Nov; 103(2):171-80. PubMed ID: 8292093 [TBL] [Abstract][Full Text] [Related]
22. Stanol ester margarine alone and with simvastatin lowers serum cholesterol in families with familial hypercholesterolemia caused by the FH-North Karelia mutation. Vuorio AF; Gylling H; Turtola H; Kontula K; Ketonen P; Miettinen TA Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):500-6. PubMed ID: 10669649 [TBL] [Abstract][Full Text] [Related]
23. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease. French JK; White HD; Greaves SC N Z Med J; 1990 Feb; 103(883):41-3. PubMed ID: 2304688 [TBL] [Abstract][Full Text] [Related]
24. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs. Illingworth DR; Bacon S Arteriosclerosis; 1989; 9(1 Suppl):I121-34. PubMed ID: 2492189 [TBL] [Abstract][Full Text] [Related]
25. Early statin therapy restores endothelial function in children with familial hypercholesterolemia. de Jongh S; Lilien MR; op't Roodt J; Stroes ES; Bakker HD; Kastelein JJ J Am Coll Cardiol; 2002 Dec; 40(12):2117-21. PubMed ID: 12505222 [TBL] [Abstract][Full Text] [Related]
26. Suboptimal consideration and management of potential familial hypercholesterolaemia in patients with suspected premature coronary artery disease. Yudi M; Omera L; McCubbery N; Dick S; Jayasinghe R; Hamilton-Craig I Singapore Med J; 2012 Mar; 53(3):174-8. PubMed ID: 22434290 [TBL] [Abstract][Full Text] [Related]
27. Treatment of primary hypercholesterolaemia. Short-term efficacy and safety of increasing doses of simvastatin and pravastatin: a double-blind comparative study. Stalenhoef AF; Lansberg PJ; Kroon AA; Kortmann B; De Haan AF; Stuyt PM; Kastelein JJ J Intern Med; 1993 Jul; 234(1):77-82. PubMed ID: 8326293 [TBL] [Abstract][Full Text] [Related]
28. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658 [TBL] [Abstract][Full Text] [Related]
29. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force. Lozano P; Henrikson NB; Dunn J; Morrison CC; Nguyen M; Blasi PR; Anderson ML; Whitlock EP JAMA; 2016 Aug; 316(6):645-55. PubMed ID: 27532919 [TBL] [Abstract][Full Text] [Related]
30. Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia. Thiery J; Creutzfeldt C; Creutzfeldt W; Walli AK; Seidel D Klin Wochenschr; 1990 Aug; 68(16):814-22. PubMed ID: 2214604 [TBL] [Abstract][Full Text] [Related]
31. Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia. van Wissen S; Smilde TJ; Trip MD; de Boo T; Kastelein JJ; Stalenhoef AF Heart; 2003 Aug; 89(8):893-6. PubMed ID: 12860867 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of triple therapy (fluvastatin-bezafibrate-cholestyramine) for severe familial hypercholesterolemia. Leitersdorf E; Muratti EN; Eliav O; Peters TK Am J Cardiol; 1995 Jul; 76(2):84A-88A. PubMed ID: 7604807 [TBL] [Abstract][Full Text] [Related]
33. Baseline lipid values partly determine the response to high-dose simvastatin in patients with familial hypercholesterolemia. The examination of probands and relatives in Statin studies with familial hypercholesterolemia (ExPRESS FH). de Sauvage Nolting PR; Buirma RJ; Hutten BA; Kastelein JJ; Atherosclerosis; 2002 Oct; 164(2):347-54. PubMed ID: 12204807 [TBL] [Abstract][Full Text] [Related]
34. Tolerability and effects of high doses acipimox as additional lipid-lowering therapy in familial hypercholesterolemia. Stuyt PM; Kleinjans HA; Stalenhoef AF Neth J Med; 1998 Nov; 53(5):228-33. PubMed ID: 9852713 [TBL] [Abstract][Full Text] [Related]
35. Treatment pattern of familial hypercholesterolemia in Slovakia: Targets, treatment and obstacles in common practice. Vohnout B; Fábryová Ľ; Klabník A; Kadurová M; Bálinth K; Kozárová M; Bugáňová I; Sirotiaková J; Rašlová K Atherosclerosis; 2018 Oct; 277():323-326. PubMed ID: 30270066 [TBL] [Abstract][Full Text] [Related]
36. Atorvastatin compared with simvastatin in patients with severe LDL hypercholesterolaemia treated by regular LDL apheresis. Geiss HC; Parhofer KG; Schwandt P J Intern Med; 1999 Jan; 245(1):47-55. PubMed ID: 10095816 [TBL] [Abstract][Full Text] [Related]
37. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group. Lambert M; Lupien PJ; Gagné C; Lévy E; Blaichman S; Langlois S; Hayden M; Rose V; Clarke JT; Wolfe BM; Clarson C; Parsons H; Stephure DK; Potvin D; Lambert J Pediatrics; 1996 May; 97(5):619-28. PubMed ID: 8628597 [TBL] [Abstract][Full Text] [Related]
38. [Effects of simvastatin on atherogenic blood lipid pattern]. Alessandri C; Peverini F; Basili S; Barsi R; Paradiso M; Marotta P; Censi C; Cordova C; Balsano F Recenti Prog Med; 1991 Apr; 82(4):225-9. PubMed ID: 1857842 [TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of severe familial hypercholesterolemia in patients presenting for cardiac catheterization. Zafrir B; Shapira C; Lavie G; Halon DA; Flugelman MY J Clin Lipidol; 2016; 10(6):1338-1343. PubMed ID: 27919350 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and tolerability of medium-term treatment with simvastatin in primary hypercholesterolaemia. Marnini P; Colombo F; Cattaneo R; Geroli L; Venco A Int J Clin Pharmacol Res; 1992; 12(2):65-70. PubMed ID: 1428300 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]